Literature DB >> 21728008

[From tumor tissue via primary cultures to xenograft models: a functional approach in prostate cancer research].

M Saar1, J Kamradt, V Jung, M Stöckle, G Unteregger.   

Abstract

The clinical course of prostate cancer, the most common cancer in men, is very variable. Despite intense research activities over the years and besides histopathological criteria, prognostic markers that reliably predict tumor behavior and the necessity for treatment are still missing. A likely explanation for this fact is the lack of good tumor models, mimicking the in vivo situation. These models are not only essential for a better understanding of the pathogenesis of prostate cancer but also play an important role in the development of new therapeutic strategies. Since results of permanent cell culture experiments reflect only in part real tumor behavior and primary cultures from patient material cannot be grown indefinitely, novel approaches need to be developed to achieve reliable and clinically relevant prostate cancer research.In this work the development of several approaches for culturing primary prostate cancer tissue is illustrated and a forecast of future research plans utilizing xenograft models in mice is made.

Entities:  

Mesh:

Year:  2011        PMID: 21728008     DOI: 10.1007/s00120-011-2630-7

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  44 in total

1.  Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant.

Authors:  Shihua Sun; Cynthia C T Sprenger; Robert L Vessella; Kathleen Haugk; Kathryn Soriano; Elahe A Mostaghel; Stephanie T Page; Ilsa M Coleman; Holly M Nguyen; Huiying Sun; Peter S Nelson; Stephen R Plymate
Journal:  J Clin Invest       Date:  2010-07-19       Impact factor: 14.808

Review 2.  Primary cell cultures as models of prostate cancer development.

Authors:  D M Peehl
Journal:  Endocr Relat Cancer       Date:  2005-03       Impact factor: 5.678

3.  Cancer-associated fibroblasts enhance the gland-forming capability of prostate cancer stem cells.

Authors:  Chun-Peng Liao; Helty Adisetiyo; Mengmeng Liang; Pradip Roy-Burman
Journal:  Cancer Res       Date:  2010-08-31       Impact factor: 12.701

Review 4.  Use of nude mouse xenograft models in prostate cancer research.

Authors:  W M van Weerden; J C Romijn
Journal:  Prostate       Date:  2000-06-01       Impact factor: 4.104

5.  Evidence of epithelial to mesenchymal transition associated with increased tumorigenic potential in an immortalized normal prostate epithelial cell line.

Authors:  Calin O Marian; Lin Yang; Ying S Zou; Crystal Gore; Rey-Chen Pong; Jerry W Shay; Wareef Kabbani; Jer-Tsong Hsieh; Ganesh V Raj
Journal:  Prostate       Date:  2010-10-13       Impact factor: 4.104

6.  Tumor-promoting phenotype of CD90hi prostate cancer-associated fibroblasts.

Authors:  Hongjuan Zhao; Donna M Peehl
Journal:  Prostate       Date:  2009-06-15       Impact factor: 4.104

Review 7.  Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits.

Authors:  Kornelia Polyak; Robert A Weinberg
Journal:  Nat Rev Cancer       Date:  2009-03-05       Impact factor: 60.716

Review 8.  Maximizing mouse cancer models.

Authors:  Kristopher K Frese; David A Tuveson
Journal:  Nat Rev Cancer       Date:  2007-09       Impact factor: 60.716

9.  Regulation of basic fibroblast growth factor expression by transforming growth factor beta in cultured human prostate stromal cells.

Authors:  M T Story; K A Hopp; D A Meier
Journal:  Prostate       Date:  1996-04       Impact factor: 4.104

10.  [From SKY, chips and proteomics. Molecular medicine in the time of high technology].

Authors:  V Rohde; A Wellmann; N Wernert; G Unteregger; B Wullich
Journal:  Urologe A       Date:  2002-03       Impact factor: 0.803

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.